Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 11, 2011 - Issue 3
Submit an article Journal homepage
95
Views
53
CrossRef citations to date
0
Altmetric
Research Report

European countries with small populations can obtain low prices for drugs: Lithuania as a case history

Kristina Garuoliene Department of Pathology, Forensic Medicine and Pharmacology, Faculty of Medicine, University of Vilnius, MK Čiurlionio g. 21/27, Vilnius, Lithuania; Medicines Reimbursement Department, National Health Insurance Fund, Kalvarijų str. 147, Vilnius, Lithuania; Department of Pathology, Forensic Medicine and Pharmacology, Faculty of Medicine, University of Vilnius, MK Čiurlionio g. 21/27, Vilnius, Lithuania; Medicines Reimbursement Department, National Health Insurance Fund, Kalvarijų str. 147, Vilnius, Lithuania
,
Brian Godman Institute for Pharmacological Research ‘Mario Negri’, Via Giuseppe La Masa 19, 20156 Milan, Italy. [email protected]; Prescribing Research Group, University of Liverpool Management School, Chatham Street, Liverpool, L69 7ZH, UK; Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, SE-141 86, Stockholm, Sweden; Institute for Pharmacological Research ‘Mario Negri’, Via Giuseppe La Masa 19, 20156 Milan, Italy. [email protected]; Prescribing Research Group, University of Liverpool Management School, Chatham Street, Liverpool, L69 7ZH, UK; Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, SE-141 86, Stockholm, Sweden
,
Jolanta Gulbinovič Department of Pathology, Forensic Medicine and Pharmacology, Faculty of Medicine, University of Vilnius, MK Čiurlionio g. 21/27, Vilnius, Lithuania; Department of Pathology, Forensic Medicine and Pharmacology, Faculty of Medicine, University of Vilnius, MK Čiurlionio g. 21/27, Vilnius, Lithuania
,
Björn Wettermark Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, SE-141 86, Stockholm, Sweden; Centre for Pharmacoepidemiology, Karolinska Institute, Karolinska University Hospital, Solna, Stockholm, Sweden; Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, SE-141 86, Stockholm, Sweden; Centre for Pharmacoepidemiology, Karolinska Institute, Karolinska University Hospital, Solna, Stockholm, Sweden
&
Alan Haycox Prescribing Research Group, University of Liverpool Management School, Chatham Street, Liverpool, L69 7ZH, UK; Prescribing Research Group, University of Liverpool Management School, Chatham Street, Liverpool, L69 7ZH, UK
Pages 343-349 | Published online: 09 Jan 2014

Citations (53)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (18)

Saad Abdullah, Zikria Saleem & Brian Godman. (2023) Coping with increasing medicine costs through greater adoption of generic prescribing and dispensing in Pakistan as an exemplar country. Expert Review of Pharmacoeconomics & Outcomes Research 0:0, pages 1-4.
Read now
Holly McCabe, Brian Godman, Amanj Kurdi, Katie Johnston, Sean MacBride-Stewart, Janey Lennon, Simon Hurding, Marion Bennie & Alec Morton. (2019) Prescribing trends of inhaler treatments for asthma and chronic obstructive pulmonary disease within a resource-constrained environment in the Scottish national health service: findings and implications. Expert Review of Respiratory Medicine 13:7, pages 679-689.
Read now
Nika Mardetko, Mitja Kos & Sabine Vogler. (2019) Review of studies reporting actual prices for medicines. Expert Review of Pharmacoeconomics & Outcomes Research 19:2, pages 159-179.
Read now
Axel Leporowski, Brian Godman, Amanj Kurdi, Sean MacBride-Stewart, Margaret Ryan, Simon Hurding, Renata CRM Do Nascimento, Marion Bennie & Alec Morton. (2018) Ongoing activities to optimize the quality and efficiency of lipid-lowering agents in the Scottish national health service: influence and implications. Expert Review of Pharmacoeconomics & Outcomes Research 18:6, pages 655-666.
Read now
Vafa Abilova, Amanj Kurdi & Brian Godman. (2018) Ongoing initiatives in Azerbaijan to improve the use of antibiotics; findings and implications. Expert Review of Anti-infective Therapy 16:1, pages 77-84.
Read now
Joseph O Fadare, Adekunle O. Adeoti, Olufemi O. Desalu, Okezie O. Enwere, Aliyu M. Makusidi, Olayinka Ogunleye, Taofiki A. Sunmonu, Ilse Truter, Onyinye O Akunne & Brian Godman. (2016) The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians. Expert Review of Pharmacoeconomics & Outcomes Research 16:5, pages 639-650.
Read now
Kristina Garuolienė, Brian Godman, Jolanta Gulbinovič, Krijn Schiffers & Björn Wettermark. (2016) Differences in utilization rates between commercial and administrative databases: implications for future health-economic and cross-national studies. Expert Review of Pharmacoeconomics & Outcomes Research 16:2, pages 149-152.
Read now
Hye-Young Kwon, Hyungmin Kim, Brian Godman & Michael R Reich. (2015) The impact of South Korea’s new drug-pricing policy on market competition among off-patent drugs. Expert Review of Pharmacoeconomics & Outcomes Research 15:6, pages 1007-1014.
Read now
Brian Godman, Iain Bishop, Stephen M Campbell, Rickard E Malmström & Ilse Truter. (2015) Quality and efficiency of statin prescribing across countries with a special focus on South Africa; findings and future implications. Expert Review of Pharmacoeconomics & Outcomes Research 15:2, pages 323-330.
Read now
Jurij Fürst, Milan Čižman, Jana Mrak, Damjan Kos, Stephen Campbell, Samuel Coenen, Lars L Gustafsson, Luka Fürst & Brian Godman. (2015) The influence of a sustained multifaceted approach to improve antibiotic prescribing in Slovenia during the past decade: findings and implications. Expert Review of Anti-infective Therapy 13:2, pages 279-289.
Read now
Alessandra Ferrario, Dragana Baltezarević, Tanja Novakovic, Mark Parker & Janko Samardzic. (2014) Evidence-based decision making in healthcare in Central Eastern Europe. Expert Review of Pharmacoeconomics & Outcomes Research 14:5, pages 611-615.
Read now
Brian Godman, Iain Bishop, Alexander E Finlayson, Stephen Campbell, Hye-Young Kwon & Marion Bennie. (2013) Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries. Expert Review of Pharmacoeconomics & Outcomes Research 13:4, pages 469-482.
Read now
Magdalena Wladysiuk, Anna Tabor & Brian Godman. (2013) ‘HTA for Crisis’: sharing experiences during the 7th EBHC Symposium. Expert Review of Pharmacoeconomics & Outcomes Research 13:1, pages 47-49.
Read now
Jessica Fraeyman, Guido Van Hal, Brian Godman & Philippe Beutels. (2013) The potential influence of various initiatives to improve rational prescribing for proton pump inhibitors and statins in Belgium. Expert Review of Pharmacoeconomics & Outcomes Research 13:1, pages 141-151.
Read now
Pieter Dylst, Arnold Vulto & Steven Simoens. (2013) Demand-side policies to encourage the use of generic medicines: an overview. Expert Review of Pharmacoeconomics & Outcomes Research 13:1, pages 59-72.
Read now
Anna Bucsics, Brian Godman, Thomas Burkhardt, Manuela Schmitzer & Rickard E Malmström. (2012) Influence of lifting prescribing restrictions for losartan on subsequent sartan utilization patterns in Austria: implications for other countries. Expert Review of Pharmacoeconomics & Outcomes Research 12:6, pages 809-819.
Read now
Vanda Markovic-Pekovic, Ranko Škrbić, Brian Godman & Lars L Gustafsson. (2012) Ongoing initiatives in the Republic of Srpska to enhance prescribing efficiency: influence and future directions. Expert Review of Pharmacoeconomics & Outcomes Research 12:5, pages 661-671.
Read now
Mohammed Abuelkhair, Shajahan Abdu, Brian Godman, Sahar Fahmy, Rickard E Malmström & Lars L Gustafsson. (2012) Imperative to consider multiple initiatives to maximize prescribing efficiency from generic availability: case history from Abu Dhabi. Expert Review of Pharmacoeconomics & Outcomes Research 12:1, pages 115-124.
Read now

Articles from other publishers (35)

Brian Godman, Magdalene Wladysiuk, Stuart McTaggart, Amanj Kurdi, Eleonora Allocati, Mihajlo Jakovljevic, Francis Kalemeera, Iris Hoxha, Anna Nachtnebel, Robert Sauermann, Manfred Hinteregger, Vanda Marković-Peković, Biljana Tubic, Guenka Petrova, Konstantin Tachkov, Juraj Slabý, Radka Nejezchlebova, Iva Selke Krulichová, Ott Laius, Gisbert Selke, Irene Langner, András Harsanyi, András Inotai, Arianit Jakupi, Svens Henkuzens, Kristina Garuolienė, Jolanta Gulbinovič, Patricia Vella Bonanno, Jakub Rutkowski, Skule Ingeberg, Øyvind Melien, Ileana Mardare, Jurij Fürst, Sean MacBride-Stewart, Carol Holmes, Caridad Pontes, Corinne Zara, Marta Turu Pedrola, Mikael Hoffmann, Vasileios Kourafalos, Alice Pisana, Rita Banzi, Stephen Campbell & Bjorn Wettermark. (2021) Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications. BioMed Research International 2021, pages 1-16.
Crossref
Brian Godman, Joseph Fadare, Hye-Young Kwon, Carolina Zampirolli Dias, Amanj Kurdi, Isabella Piassi Dias Godói, Dan Kibuule, Iris Hoxha, Sylvia Opanga, Zikria Saleem, Tomasz Bochenek, Vanda Marković-Peković, Ileana Mardare, Aubrey C Kalungia, Stephen Campbell, Eleonora Allocati, Alice Pisana, Antony P Martin & Johanna C Meyer. (2021) Evidence-based public policy making for medicines across countries: findings and implications for the future. Journal of Comparative Effectiveness Research 10:12, pages 1019-1052.
Crossref
Maryam Rangchian, Zeinab Bagheri & Najmeh Moradi. (2020) Managing Pharmaceutical Expenditures: Estimating the Effect of Internal Reference Pricing for Three Pharmacological Categories. Avicenna Journal of Pharmaceutical Research 1:2, pages 76-81.
Crossref
Peter Schneider & Sabine Vogler. 2019. Medicine Price Surveys, Analyses and Comparisons. Medicine Price Surveys, Analyses and Comparisons 113 164 .
Begashaw Melaku Gebresillassie, Sewunet Admasu Belachew, Yonas Getaye Tefera, Tamrat Befekadu Abebe, Abebe Basazn Mekuria, Kaleab Taye Haile & Daniel Asfaw Erku. (2018) Evaluating patients’, physicians’ and pharmacy professionals’ perception and concern regarding generic medicines in Gondar town, northwest Ethiopia: A multi-stakeholder, cross-sectional survey. PLOS ONE 13:11, pages e0204146.
Crossref
Josephine Walker, Betty B. Chaar, Numa Vera, Alvish S. Pillai, Jessy S. Lim, Lisa Bero & Rebekah J. Moles. (2017) Medicine shortages in Fiji: A qualitative exploration of stakeholders’ views. PLOS ONE 12:6, pages e0178429.
Crossref
Ingrida Lisauskienė, Kristina Garuolienė & Jolanta Gulbinovič. (2017) Utilization of cardiovascular medicines and cardiovascular mortality in Lithuania, Sweden and Norway in 2003–2012. Medicina 53:4, pages 259-267.
Crossref
Natasha Azzopardi-Muscat, Tjede Funk, Sandra C. Buttigieg, Kenneth E. Grech & Helmut Brand. (2016) Policy challenges and reforms in small EU member state health systems: a narrative literature review. The European Journal of Public Health 26:6, pages 916-922.
Crossref
Winnie de Bruijn, Cristina Ibáñez, Pia Frisk, Hanne Bak Pedersen, Ali Alkan, Patricia Vella Bonanno, Ljiljana S. Brkičić, Anna Bucsics, Guillaume Dedet, Jaran Eriksen, Joseph O. Fadare, Jurij Fürst, Gisselle Gallego, Isabella P. Godói, Augusto A. Guerra Júnior, Hakkı Gürsöz, Saira Jan, Jan Jones, Roberta Joppi, Saim Kerman, Ott Laius, Newman Madzikwa, Einar Magnússon, Mojca Maticic, Vanda Markovic-Pekovic, Amos Massele, Olayinka Ogunleye, Aisling O'Leary, Jutta Piessnegger, Catherine Sermet, Steven Simoens, Celda Tiroyakgosi, Ilse Truter, Magnus Thyberg, Kristina Tomekova, Magdalena Wladysiuk, Sotiris Vandoros, Elif H. Vural, Corinne Zara & Brian Godman. (2016) Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future. Frontiers in Pharmacology 7.
Crossref
Onyinye Onyeka Akunne, Brian Godman, Aduragbenro Deborah Adedapo, Ilse Truter & Joseph Fadare. (2016) Statin prescribing among hypertensive patients in southwest Nigeria: findings and implications for the future. Journal of Comparative Effectiveness Research 5:3, pages 281-288.
Crossref
Mihajlo Jakovljevic. (2016) Commentary: Patient Cost Sharing and Medical Expenditures for the Elderly. Frontiers in Pharmacology 7.
Crossref
Elisabetta Poluzzi, Giacomo Veronese, Carlo Piccinni, Emanuel Raschi, Ariola Koci, Paola Pagano, Brian Godman, Giulio Marchesini, Giuseppe Boriani & Fabrizio De Ponti. (2016) Switching among Equivalents in Chronic Cardiovascular Therapies: ‘Real World’ Data from Italy. Basic & Clinical Pharmacology & Toxicology 118:1, pages 63-69.
Crossref
Suzanne S. Dunne & Colum P. Dunne. (2015) What do people really think of generic medicines? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugs. BMC Medicine 13:1.
Crossref
Leos Fuksa, Milan Vocelka & Magda Vytrisalova. (2015) The impact of changes in national prescribing conditions for statins on their public expenditure and utilization in the Czech Republic 1997–2013. Health Policy 119:9, pages 1255-1264.
Crossref
Humayun Riaz, Brian Godman, Shahzad Hussain, Farnaz Malik, Sidra Mahmood, Ali Shami & Sajid Bashir. (2015) Prescribing of bisphosphonates and antibiotics in Pakistan: challenges and opportunities for the future. Journal of Pharmaceutical Health Services Research 6:2, pages 111-121.
Crossref
Elisabetta Poluzzi, Emanuel Raschi, Brian Godman, Ariola Koci, Ugo Moretti, Marija Kalaba, Bjorn Wettermark, Miriam Sturkenboom & Fabrizio De Ponti. (2015) Pro-Arrhythmic Potential of Oral Antihistamines (H1): Combining Adverse Event Reports with Drug Utilization Data across Europe. PLOS ONE 10:3, pages e0119551.
Crossref
Ilse Truter, Sushma Shankar, Marion Bennie, Menno van Woerkom & Brian Godman. (2015) Initiatives in South Africa to enhance the prescribing of generic proton pump inhibitors: findings and implications. Journal of Comparative Effectiveness Research 4:2, pages 123-131.
Crossref
François Bocquet, Pascal Paubel, Isabelle Fusier, Anne-Laure Cordonnier, Martine Sinègre & Claude Le Pen. (2014) Biosimilar Versus Patented Erythropoietins: Learning from 5 Years of European and Japanese Experience. Applied Health Economics and Health Policy 13:1, pages 47-59.
Crossref
Brian Godman, Max Petzold, Kathleen Bennett, Marion Bennie, Anna Bucsics, Alexander E Finlayson, Andrew Martin, Marie Persson, Jutta Piessnegger, Emanuel Raschi, Steven Simoens, Corinne Zara & Corrado Barbui. (2014) Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications. BMC Medicine 12:1.
Crossref
Marina Polić-Vižintin, Danijela Štimac, Zvonimir Šostar & Ingrid Tripković. (2014) Distribution and trends in outpatient utilization of generic versusbrand name psychopharmaceuticals during a ten-year period in Croatia. BMC Health Services Research 14:1.
Crossref
James C. Moon, Brian Godman, Max Petzold, Samantha Alvarez-Madrazo, Kathleen Bennett, Iain Bishop, Anna Bucsics, Ulrik Hesse, Andrew Martin, Steven Simoens, Corinne Zara & Rickard E. Malmström. (2014) Different initiatives across Europe to enhance losartan utilization post generics: impact and implications. Frontiers in Pharmacology 5.
Crossref
Thirimon Moe-Byrne, Duncan Chambers, Melissa Harden & Catriona McDaid. (2014) Behaviour change interventions to promote prescribing of generic drugs: a rapid evidence synthesis and systematic review. BMJ Open 4:5, pages e004623.
Crossref
François Bocquet, Pascal Paubel, Isabelle Fusier, Anne-Laure Cordonnier, Claude Le Pen & Martine Sinègre. (2014) Biosimilar Granulocyte Colony-Stimulating Factor Uptakes in the EU-5 Markets: A Descriptive Analysis. Applied Health Economics and Health Policy.
Crossref
Suzanne Dunne, Bill Shannon, Colum Dunne & Walter Cullen. (2013) A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study. BMC Pharmacology and Toxicology 14:1.
Crossref
Brian Godman, Alexander E Finlayson, Parneet K Cheema, Eva Zebedin-Brandl, Inaki Gutiérrez-Ibarluzea, Jan Jones, Rickard E Malmström, Elina Asola, Christoph Baumgärtel, Marion Bennie, Iain Bishop, Anna Bucsics, Stephen Campbell, Eduardo Diogene, Alessandra Ferrario, Jurij Fürst, Kristina Garuoliene, Miguel Gomes, Katharine Harris, Alan Haycox, Harald Herholz, Krystyna Hviding, Saira Jan, Marija Kalaba, Christina Kvalheim, Ott Laius, Sven-Ake Lööv, Kamila Malinowska, Andrew Martin, Laura McCullagh, Fredrik Nilsson, Ken Paterson, Ulrich Schwabe, Gisbert Selke, Catherine Sermet, Steven Simoens, Dominik Tomek, Vera Vlahovic-Palcevski, Luka Voncina, Magdalena Wladysiuk, Menno van Woerkom, Durhane Wong-Rieger, Corrine Zara, Raghib Ali & Lars L Gustafsson. (2013) Personalizing health care: feasibility and future implications. BMC Medicine 11:1.
Crossref
Ulrik Hesse, Brian Godman, Max Petzold, Andrew Martin & Rickard E. Malmström. (2013) Impact of Delisting ARBs, Apart from Losartan, on ARB Utilisation Patterns in Denmark: Implications for Other Countries. Applied Health Economics and Health Policy 11:6, pages 677-685.
Crossref
Steven Simoens, Kristien De Bruyn, Jamilette Miranda, Marion Bennie, Rickard E. Malmström & Brian Godman. (2013) Measures to enhance angiotensin-receptor blocker prescribing efficiency in Belgium following generic losartan: impact and implications for the future. Journal of Pharmaceutical Health Services Research 4:3, pages 173-181.
Crossref
Brian Godman, Marie Persson, Jamilette Miranda, Peter Skiöld, Björn Wettermark, Corrado Barbui & Lars L. Gustafsson. (2013) Changes in the Utilization of Venlafaxine after the Introduction of Generics in Sweden. Applied Health Economics and Health Policy 11:4, pages 383-393.
Crossref
Su-Yeon Yu, Bong-Min Yang & Jin-Hyun Kim. (2013) New Anti-Rebate Legislation in South Korea. Applied Health Economics and Health Policy 11:4, pages 311-318.
Crossref
Sylvain Pichetti, Catherine Sermet, Brian Godman, Stephen M. Campbell & Lars L. Gustafsson. (2013) Multilevel Analysis of the Influence of Patients’ and General Practitioners’ Characteristics on Patented Versus Multiple-Sourced Statin Prescribing in France. Applied Health Economics and Health Policy 11:3, pages 205-218.
Crossref
M. Bennie, I. Bishop, B. Godman, C. Barbui, E. Raschi, S. Campbell, J. Miranda & L. L. Gustafsson. (2013) Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland?: International implications. International Journal of Clinical Practice 67:2, pages 170-180.
Crossref
Brian Godman & Lars L. Gustafsson. (2013) A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing. Applied Health Economics and Health Policy 11:1, pages 79-82.
Crossref
Caitriona Cahir, Tom Fahey, Lesley Tilson, Conor Teljeur & Kathleen Bennett. (2012) Proton pump inhibitors: potential cost reductions by applying prescribing guidelines. BMC Health Services Research 12:1.
Crossref
Marija KalabaBrian Godman, Aleksandar Vuksanović, Marion Bennie & Richard E Malmström. (2012) Possible ways to enhance renin–angiotensin prescribing efficiency: Republic of Serbia as a case history?. Journal of Comparative Effectiveness Research 1:6, pages 539-549.
Crossref
Menno van Woerkom, Hans Piepenbrink, Brian GodmanJoost de Metz, Stephen Campbell, Marion Bennie, Marietta Eimers & Lars L Gustafsson. (2012) Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in The Netherlands: influence and future implications. Journal of Comparative Effectiveness Research 1:6, pages 527-538.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.